BrightSpring Health Services IncBTSG
Price$57.26Intrinsic value$69.6622% above price

Qualitative Analysis

Business overview

Business Overview

BrightSpring Health Services, Inc. (NASDAQ: BTSG) is a leading home- and community-based healthcare services platform in the United States. The company operates through two primary segments: Pharmacy Solutions and Provider Services. Pharmacy Solutions focuses on infusion, specialty, and institutional pharmacy services, while Provider Services encompasses home health, hospice, rehabilitation therapy, and supportive care services. BrightSpring serves over 400,000 complex, high-need patients daily across all 50 states through its extensive network of clinical providers and pharmacists.

Research as of 19 Jun 2026

Strategic Initiatives

Growth programs, investments, and their expected impact

AI-assisted
CCRx (Continue CareRx) Program ExpansionInnovation

A longitudinal medication therapy and risk management program for home health patients that integrates pharmacy and provider services to improve medication adherence and reduce hospitalizations.

Expected impact: Proven to reduce hospitalization rates by 73.1% for enrolled home health recipients, driving better clinical outcomes and value-based care alignment.

Sign in / Sign up to read more
InvestmentOngoing operational and technology integration investments.
TimelineLaunched in 2021, with continuous expansion and integration across home health lines through 2026.
Portfolio Optimization & De-leveragingTransformation

Divesting non-core assets to focus capital and resources on high-growth, high-margin home health, hospice, rehab, primary care, and specialty pharmacy segments.

Expected impact: Streamlines the business model, improves payer mix, and reduces leverage toward the 2.5x target using $715 million in net proceeds.

Sign in / Sign up to read more
InvestmentFunded through divestiture proceeds.
TimelineCompleted the ResCare Community Living sale in Q1 2026; debt paydown ongoing through 2026.
Sources: 2

Mergers, Acquisitions & Partnerships

Recent deals and strategic collaborations

AI-assisted

Recent Acquisitions

Amedisys and LHC Group Branches (107 branches)$239M

Acquisition of geographically complementary home health and hospice branches divested during the UnitedHealth Group acquisition of Amedisys.

Financial impact: Generated $345 million in pro forma 2025 revenue and is expected to contribute approximately $30 million in Adjusted EBITDA in 2026.

Sign in / Sign up to read more
Sources: 1
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.